55687-00-8 Usage
Uses
Used in Research and Chemical Industries:
Quinoxaline, 2-chloro-6-methyl-, is used as a research chemical and in chemical synthesis processes due to its increased reactivity and unique properties. Its chlorinated and methylated structure makes it a valuable compound for various applications in these industries.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, Quinoxaline, 2-chloro-6-methyl-, is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its reactivity and unique structure make it a promising candidate for the development of new drugs and therapeutic agents.
Used in Material Science:
Quinoxaline, 2-chloro-6-methyl-, is also utilized in material science for the development of novel materials with specific properties. Its unique structure and reactivity contribute to the creation of advanced materials with potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 55687-00-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,6,8 and 7 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 55687-00:
(7*5)+(6*5)+(5*6)+(4*8)+(3*7)+(2*0)+(1*0)=148
148 % 10 = 8
So 55687-00-8 is a valid CAS Registry Number.
55687-00-8Relevant articles and documents
TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE
-
Page/Page column 83, (2010/11/28)
Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.
Tethering identifies fragment that yields potent inhibitors of human caspase-1
Fahr, Bruce T.,O'Brien, Tom,Pham, Phuongly,Waal, Nathan D.,Baskaran, Subramanian,Raimundo, Brian C.,Lam, Joni W.,Sopko, Michelle M.,Purkey, Hans E.,Romanowski, Michael J.
, p. 559 - 562 (2007/10/03)
Disulfide Tethering was applied to the active site of human caspase-1, resulting in the discovery of a novel, tricyclic molecular fragment that selectively binds in S4. This fragment was developed into a class of potent inhibitors of human caspase-1. Seve
